Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...
In this Market Dialogues episode, experts discuss what’s driving efforts to connect private market data with public workflows ...
The trading range for stock earnings multiples has shifted higher, quite possibly permanently, says Jim Paulsen ...
In the assessment of 12-month price targets, analysts unveil insights for Palantir Technologies, presenting an average target ...
The U.S. dollar has always been a critical measure of the health of the global economy, but recently this barometer has found ...
BigShort, which officially launched in 2024, is a trading indicator platform designed to give users greater visibility into ...
Crypto miner Cipher Mining (CIFR) soared nearly 20% in pre-market on Monday after announcing a $5.5 billion, 15-year deal ...
1d
It's Just a 'Cookie'—Until It’s a Lawsuit: Why Website-Tracking Risks Have Become Too Big to Ignore
If you’re looking to minimize litigation risk, opt-in consent is realistically the only thing that works,” said Elliot Golding, a partner at McDermott Will & Schulte. “But that’s a tough pill for a ...
UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy for Huntington's disease may be adequate for a marketing application, ...
In this StockAnalysis Free Newsletter review, I’ll share why this free daily update has quietly become one of the most ...
Overview Artificial Intelligence is transforming trading from rule-based automation to intelligent, data-driven decision-making.ESG integration is turning susta ...
Regulatory measures to rein in retail investor frenzy for options trading begins bearing fruit since they took effect in Nov ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback